Letter to the Editor: Serendipity during Sleeve Gastrectomy —Blood Supply Might Be Fundamental for Hunger and Satiety
The use of antihypertensive medications has been shown to significantly decrease in most morbidly obese patients who undergo sleeve gastrectomy (SG) surgery, with 58% of patients having complete resolution of their hypertension. It is unknown if this same effect is seen in morbidly obese patients with left ventricular assist devices (LVAD) who undergo SG.
Patients with left ventricular assist devices (LVADs) who are morbidly obese cannot be easily bridged to heart transplantation (HT). Reported UNOS data show that the survival rate of such patients was low after HT. Some patients are obese at the time of LVAD implantation, whereas others become morbidly obese following LVAD implantation. We applied laparoscopic sleeve gastrectomy (LSG) as a treatment strategy and our study looked to determine its efficacy and safety.
ConclusionsIn patients aged 40 ‐65, gastric bypass but not sleeve gastrectomy or the other procedures increased risk of major osteoporotic fractures.This article is protected by copyright. All rights reserved.
Condition: Weight Loss Interventions: Drug: Liraglutide 6 MG/ML; Drug: Placebos Sponsor: Postgraduate Institute of Medical Education and Research Completed
ConclusionsForegut pathology is common in bariatric patients with subjective symptoms of GERD. Implementing a comprehensive protocol to objectively assess these patients leads to a significant clinical impact on which procedure these patients ultimately undergo.
This study included patients who underwent primary laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG). The primary outcome of interest was incisional SSI occurring within 30 days. Surgeries performed in 2015 were used in a derivation cohort and the predictive tool was validated against the 2016 cohort. A forward selection algorithm was used to build a logistic regression model predicting probability of SSI.ResultsA total of 274,187 patients were included with 71.7% being LSG and 28.3% LRYGB. 0.7% of patients had a SSI in which 71.0% had an incisional SSI, and 29.9% had an organ/spa...
Objective: We sought to compare the short and long-term outcomes of MBS in adolescents vs. adults who have undergone a Roux-en-Y gastric bypass (RYGB) or Sleeve gastrectomy (SG).Design: Retrospective cohort study.Setting: Single tertiary care academic referral center.Participants: One hundred fifty adolescent (≤ 21-years) and adult (>21-years) subjects with severe obesity between 15 and 70 years of age who underwent RYGB or SG.Outcomes: Metabolic parameters, weight and height measures were obtained pre-and post-surgery (at 3 and 6 months, and then annually for 4 years).Results: Median pre-surgical body mass index (BM...
We examined the association of hospital length of stay (LOS) by race-ethnicity (Hispanic, non-Hispanic white [NHW], NH black [NHB]) and MBS-procedure among Florida inpatients. DESIGN: Secondary analysis of inpatient records was performed using the 2016 Florida Agency for Health Care Administrative (AHCA) data. Records of Laparoscopic Roux-en-Y Gastric Bypass (RYGB), Laparoscopic Adjustable Gastric Banding (LAGB), and Sleeve Gastrectomy (SG) procedures based on ICD 10th edition code were analyzed. Via logistic regression analysis, the adjusted odds ratio (aOR) of longer LOS (≥2 versus
AbstractBackgroundRevisional gastric bypass (R-RYGB) surgery is utilized for the management of inadequate weight loss or weight regain observed after some cases of bariatric surgeries. Data on the mid-term effectiveness of primary gastric bypass (P-RYGB) compared with R-RYGB (e.g., post sleeve gastrectomy/gastric banding) are controversial.MethodsRetrospective chart review of all patients who received P-RYGB and R-RYGB (January 2011 –June 2015) at our center. One hundred twenty patients who underwent P-RYGB and 34 R-RYGB who completed 18 months follow-up were included. We compared the effectiveness of P-RYGB with R-R...
Bariatric surgery is an effective therapeutic procedure for morbidly obese patients. The two most common interventions are Sleeve Gastrectomy (SG) and Laparoscopic Roux-en-Y Gastric Bypass (LRYGB).